Bank of Nova Scotia’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,795
Closed -$932K 1273
2022
Q3
$932K Buy
3,795
+37
+1% +$9.99K ﹤0.01% 805
2022
Q2
$930K Sell
3,758
-1,873
-33% -$505K ﹤0.01% 861
2022
Q1
$1.86M Sell
5,631
-3,025
-35% -$931K ﹤0.01% 825
2021
Q4
$3.11M Buy
8,656
+1,253
+17% +$423K ﹤0.01% 809
2021
Q3
$2.41M Buy
7,403
+675
+10% +$229K ﹤0.01% 822
2021
Q2
$2.1M Sell
6,728
-1,684
-20% -$517K ﹤0.01% 806
2021
Q1
$2.68M Buy
8,412
+830
+11% +$266K 0.01% 724
2020
Q4
$2.46M Buy
7,582
+1,852
+32% +$512K 0.01% 661
2020
Q3
$1.59M Buy
+5,730
New +$1.65M ﹤0.01% 695
2020
Q1
Sell
-1,226
Closed -$209K 984
2019
Q4
$209K Hold
1,226
﹤0.01% 899
2019
Q3
$218K Sell
1,226
-7,893
-87% -$1.71M ﹤0.01% 871
2019
Q2
$2.38M Buy
9,119
+543
+6% +$144K 0.01% 573
2019
Q1
$2.45M Sell
8,576
-45,070
-84% -$15M 0.01% 585
2018
Q4
$17.4M Buy
53,646
+28,506
+113% +$9.9M 0.08% 204
2018
Q3
$11.3M Buy
25,140
+20,469
+438% +$8.07M 0.05% 296
2018
Q2
$1.91M Buy
+4,671
New +$1.69M 0.01% 516
2016
Q3
Sell
-18,130
Closed -$1.98M 779
2016
Q2
$1.98M Buy
+18,130
New +$1.8M 0.01% 288

Other funds holding ABMD

Bank of Nova Scotia's ABMD Position: Q4 2022 in Review

Bank of Nova Scotia sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,795 shares — an estimated $932K sold.

Bank of Nova Scotia first reported a position in ABMD in Q2 2016 and held it in 17 quarters. The position peaked at $17.4M in Q4 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bank of Nova Scotia reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 3,795 Abiomed Inc shares in Q4 2022, an estimated $932K.
  • Bank of Nova Scotia first reported a position in Abiomed Inc in Q2 2016 and held it in 17 quarters.
  • Bank of Nova Scotia's Abiomed Inc position peaked at $17.4M in Q4 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bank of Nova Scotia's 13F filing for Q4 2022, filed 9 Feb 2023.